2442 related articles for article (PubMed ID: 18085692)
1. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
[TBL] [Abstract][Full Text] [Related]
2. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
[TBL] [Abstract][Full Text] [Related]
3. Predictors for failed dose reduction of inhaled corticosteroids in childhood asthma.
Li AM; Tsang TW; Lam HS; Sung RY; Chang AB
Respirology; 2008 May; 13(3):400-7. PubMed ID: 18399863
[TBL] [Abstract][Full Text] [Related]
4. Acinar effect of inhaled steroids evidenced by exhaled nitric oxide.
Van Muylem A; Kerckx Y; Michils A
J Allergy Clin Immunol; 2010 Oct; 126(4):730-735.e2. PubMed ID: 20709384
[TBL] [Abstract][Full Text] [Related]
5. Is exhaled nitric oxide a useful adjunctive test for assessing asthma?
Bernstein JA; Davis B; Alvarez-Puebla MJ; Nguyen D; Levin L; Olaguibel JM
J Asthma; 2009 Nov; 46(9):955-60. PubMed ID: 19905926
[TBL] [Abstract][Full Text] [Related]
6. High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children.
Pijnenburg MW; Bakker EM; Lever S; Hop WC; De Jongste JC
Clin Exp Allergy; 2005 Jul; 35(7):920-5. PubMed ID: 16008679
[TBL] [Abstract][Full Text] [Related]
7. Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers.
Hillas G; Kostikas K; Mantzouranis K; Bessa V; Kontogianni K; Papadaki G; Papiris S; Alchanatis M; Loukides S; Bakakos P
Respirology; 2011 Jul; 16(5):811-8. PubMed ID: 21545371
[TBL] [Abstract][Full Text] [Related]
8. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the Asthma Control Test (ACT) with lung function, levels of exhaled nitric oxide and control according to the Global Initiative for Asthma (GINA)].
Alvarez-Gutiérrez FJ; Medina-Gallardo JF; Pérez-Navarro P; Martín-Villasclaras JJ; Martin Etchegoren B; Romero-Romero B; Praena-Fernández JM
Arch Bronconeumol; 2010 Jul; 46(7):370-7. PubMed ID: 20605310
[TBL] [Abstract][Full Text] [Related]
10. The value of sputum 8-isoprostane in detecting oxidative stress in mild asthma.
Louhelainen N; Rytilä P; Obase Y; Mäkelä M; Haahtela T; Kinnula VL; Pelkonen A
J Asthma; 2008 Mar; 45(2):149-54. PubMed ID: 18350407
[TBL] [Abstract][Full Text] [Related]
11. Increased IL-17A secreting CD4+ T cells, serum IL-17 levels and exhaled nitric oxide are correlated with childhood asthma severity.
Chien JW; Lin CY; Yang KD; Lin CH; Kao JK; Tsai YG
Clin Exp Allergy; 2013 Sep; 43(9):1018-26. PubMed ID: 23957337
[TBL] [Abstract][Full Text] [Related]
12. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide metabolites in induced sputum: a noninvasive marker of airway inflammation in asthma.
Kumar L; Rajput N; Majumdar S
Indian Pediatr; 2005 Apr; 42(4):329-37. PubMed ID: 15876594
[TBL] [Abstract][Full Text] [Related]
14. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.
Smith AD; Cowan JO; Brassett KP; Herbison GP; Taylor DR
N Engl J Med; 2005 May; 352(21):2163-73. PubMed ID: 15914548
[TBL] [Abstract][Full Text] [Related]
15. Safety and application of induced sputum analysis in childhood asthma.
Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
[TBL] [Abstract][Full Text] [Related]
16. Exhaled nitric oxide decreases in association with attendance at an asthma summer cAMP.
Kaminsky DA; Rice AA; Bissonette M; Larose T; Phillips L; Cohen L; Lahiri T; Frankowski B
J Asthma; 2008 Jun; 45(5):415-9. PubMed ID: 18569236
[TBL] [Abstract][Full Text] [Related]
17. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study.
Fritsch M; Uxa S; Horak F; Putschoegl B; Dehlink E; Szepfalusi Z; Frischer T
Pediatr Pulmonol; 2006 Sep; 41(9):855-62. PubMed ID: 16850457
[TBL] [Abstract][Full Text] [Related]
18. Elevated fractional exhaled nitric oxide (FeNO) is a clinical indicator of uncontrolled asthma in children receiving inhaled corticosteroids.
Yin SS; Liu H; Gao X
Int J Clin Pharmacol Ther; 2017 Jan; 55(1):66-77. PubMed ID: 27443657
[TBL] [Abstract][Full Text] [Related]
19. Comparison of high-dose salmeterol/fluticasone and moderate-dose salmeterol/fluticasone plus low-dose mometasone in patients with severe persistent asthma.
Kurashima K; Kagiyama N; Takayanagi N; Sugita Y
Respirology; 2011 Jul; 16(5):784-9. PubMed ID: 21382132
[TBL] [Abstract][Full Text] [Related]
20. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
